BioNexus Gene Lab
BGLC
BGLC
3 hedge funds and large institutions have $30.3K invested in BioNexus Gene Lab in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
VF
Virtu Financial
New York
|
-$9.34K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$5.94K |
| 3 |
HF
HRT Financial
New York
|
-$2.96K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| $13K | -$9.34K | -1,967 | -42% |
|
2
Geode Capital Management
Boston,
Massachusetts
| $11.3K | – | – | – |
|
|
HF
3
HRT Financial
New York
| $6K | -$2.96K | -723 | -33% |
|
|
4
UBS Group
Zurich,
Switzerland
| – | -$5.94K | -842 | Closed |
|